In September, Lancaster General Health opened The Neuroscience Institute, a unique resource for patients and providers alike that is focused on comprehensive neurological care. 

Clinicians from practices and programs supporting neurological care gathered to tour their new space before the official opening.

The 22,000-square-foot institute combines the expertise, skills and compassion of LG Health’s neuroscience physicians, therapists, care coordinators and more than 70 team members in one convenient location. Together, the team treats patients with neurologic concerns ranging from stroke and movement disorders to memory issues, concussion and headache. 
 
“There is nothing like this in Central Pennsylvania,” said Timothy C. Martin, D.O., Ph.D., Managing Physician, LG Health Physicians Neurology. “Practicing in such close proximity will enable us to communicate more frequently and ask better questions. There are many benefits to referring a patient to a team member who is located down the hall instead of miles away.”
 
The institute offers a variety of services, including neurology, electro-diagnostics, neuropsychology, Alzheimer’s and memory-care issues, and physiatry. Additional specialty programs focus on dizziness and balance issues, spinal-cord injuries, movement disorders such as Parkinson’s disease, post-concussion syndrome and headaches.
 
Patients of the institute also have access to an outpatient rehabilitation area that features therapists who have advanced training and state-of-the-art equipment, including a robotic ZeroG Gait and Balance System, which supports patients who are practicing safe standing and walking.
 
“Opening the institute will enable LG Health to bolster existing services, including a robust stroke recovery program that will emphasize smooth handoffs and continuity of care from inpatient to rehab and outpatient settings,” said Brad Stevens, LG Health Executive Director, Neuroscience and Orthopedics.
 
The institute also offers teleconferencing capabilities to increase its collaboration with Penn Medicine, enabling more discussions regarding diagnosis and treatment options and providing more opportunities for LG Health patients to participate in clinical trials.

Share This Page: